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Abstract
Ths paper describes the distribution of dependence criteria and diagnoses in a sample of 14-
to 24-year-olds from Munich, Germany (n = 3,021; 71% response rate), evaluates differences
between nondependent and dependent smokers and examines associations of smoking with
other substances, affective and anxiety disorders. Assessment was made using the M-CIDI.
The lifetime prevalence of DSM-IV nicotine dependence in the total sample is 19%, rising to
52% among regular smokers. No gender differences were seen in the progression from regular
smoking to nicotine dependence, although men were more likely than women to initiate regu-
lar use. Analysis of daily cigarette use identified a significant dose-response relationship with
the number of endorsed DSM-IV dependence criteria with unsuccessful cut-backs being the
most prevalent criterion. As compared to nondependent smokers, dependent smokers were
more likely to associate negative health effects with smoking and to have a desire to change
and attempt a change in their pattern of use. Regular use of nicotine was found to be signifi-
cantly associated with other substance and nonsubstance disorders, although dependent regu-
lar use was more strongly associated with these disorders than nondependent regular use.
These results indicate that daily smoking is a behavior which is resistant to change despite an
expressed desire and repeated cut-back attempts. Although initiation of regular smoking
among nonsmokers does not occur frequently after the early twenties, the risk for dependent
smoking among regular users persists into adulthood and is associated with a range of mental
disorders.
OOOOOOOOOOOOOOOOOOOOOO
Introduction
Among other major policy statements, the publication
of the 1988 US Surgeon Generals report on smoking [1],
the testimony before the US Congress by the Director of
the US Food and Drug Administration [2] and the recent
classification of nicotine as a drug of abuse in the United
States have marked the alignment of the medical and pub-
lic health establishment against smoking and the use of
tobacco. Adding to this awareness have been a series of
reviews which summarize the evidence for classifying
nicotine as a drug of abuse [3–7] as well as the medical [8]
and economic costs of smoking [9]. Consistent with these
reports, nicotine dependence is now included as one form
of substance use disorder in the 10th International Classi-
fication of Diseases (ICD-10) [10] and the Diagnostic and
Statistical Manual of Mental Disorders (DSM) [11].
Although the association between regular smoking and
mental disorders has been investigated using data from
the St. Louis [12] and Durham sites of the Epidemiologic
Catchment Area Study [13], the assessment of DSM-
defined nicotine dependence and its association with
these disorders has been initiated only recently. The first
reports in nonclinical populations are provided by Bres-
lau et al. [14, 15] who assessed DSM-III-R diagnoses
among 21- to 30-year-old members of a Detroit area
health maintenance organization. These authors reported
that 51% of lifetime smokers met the criteria for a DSM-
III-R diagnosis and that while dependent smoking was
significantly related to other DSM-defined substance, af-
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fective and anxiety disorders, nondependent smoking was
significantly related to only substance disorder [14]. A
subsequent report by this group [15] showed that compul-
sive use is reported by about two-thirds and that with-
drawal symptoms and tolerance are reported by about
one-third of lifetime smokers, findings which are consis-
tent with those from a US general population survey of
symptoms among 12-month smokers [16].
Recently, we assessed the prevalence of various DSM-
IV substance and nonsubstance disorders in a population
of 14- to 24-year-olds in Munich, Germany, and found
that nicotine dependence was equally prevalent among
men and women and one of the most prevalent DSM-
defined disorders in the population [17]. In a further elab-
oration of these findings, this paper reports on the charac-
teristics of nondependent and dependent regular smoking
exploring age of onset, progression, the distribution of
dependence criteria at increasing levels of use, and their
association with other substance and nonsubstance disor-
ders. These analyses were prompted by: (a) the lack of epi-
demiological data about strictly defined nicotine depen-
dence in general population samples, and (b) interest in
the development of nicotine dependence and its associa-
tion with other forms of mental disorder.
Methods
Sample
This sample was drawn from 1994 government registries of resi-
dents in metropolitan Munich (1990 population 2.6 million [18])
expected to be 14–24 years of age at the time of interview during the
first half of 1995. Because the study is designed as a panel with spe-
cial interest in the development of substance disorders, 14- to 15-
year-olds were sampled at twice the probability of persons 16–21
years of age and 22- to 24-year-olds were sampled at half this proba-
bility. Among the sampled individuals, a total of 3,021 interviews
were completed resulting in a response rate of 71% (for further
details, see Wittchen et al. [17]). To account for the different sam-
pling probabilities, noncontact and nonresponse, a relative weight
[19] is used in all analyses which adjusts the data by age, sex and
geographic location to match the distribution of the sampling frame.
Almost three-quarters of the population were students, 36% at the
secondary level and 35% at university, nearly two-thirds (64%) were
living with their parents and 23% were living alone.
General Assessment
Diagnostic assessment was based on the Munich version of the
Composite International Diagnostic Interview (M-CIDI) [20]. The
M-CIDI is an updated version of the World Health Organisation’s
CIDI version 1.2 (WHO-CIDI) [21] which incorporated questions
assessing DSM-IV and ICD-10 criteria. The reliability and procedur-
al validity of the CIDI [20, 22] have been reported previously and are
reported for the M-CIDI elsewhere in this issue.
Definition of Use, Regular Use and Nicotine Dependence
For the purpose of this survey tobacco products were defined as
cigarettes, cigars, pipes, snuff or chew and regular use of one of these
tobacco products was defined as daily use for a period of at least 4
weeks. Using these criteria, almost the entire population of regular
users reported regular cigarette use (99%) with the balance reporting
exclusive regular use of chew or snuff. It should be noted that in Ger-
many the legal age for the purchase of tobacco products is 16 years,
although enforcement of this age limit is negligible since vending
machines are present in most public places.
DSM-IV criteria [11] were used to assess dependence among all
respondents indicating regular use of a tobacco product at some time
in their life. In DSM-IV, three of seven criteria must be endorsed as
occurring within the same 12-month time frame for a diagnosis to be
assigned and include: (1) tolerance; (2) withdrawal; (3) use in larger
amounts or for longer periods of time than intended; (4) a persistent
desire or unsuccessful cut-down or unsuccessful attempts at control-
ling use; (5) a great deal of time using the substance; (6) giving up
important social, occupational, or recreational activities because of
use; (7) use despite knowledge of recurrent physical or psychological
problems that are likely to have been caused or exacerbated by use. In
addition, DSM-IV specifies a diagnosis of physiologic dependence
when the criteria for tolerance or withdrawal are fulfilled.
Statistical Analysis
To account for the bias introduced by the differing lengths of fol-
low-up time for each respondent, i.e. they have different ages, surviv-
al analysis was used in analyzing the data where appropriate [23–26].
Cumulative incidence curves for age at first use, regular use and nico-
tine dependence were calculated using life table methods and the
comparison of curves was done using the log-rank test.
Using lifetime diagnoses and logistic regression models, preva-
lence odds ratios and their 95% confidence intervals (POR and 95%
CI) [24] were used to estimate the association of nondependent and
dependent regular use with co-occurring diagnoses.
For each row variable three associations were tested: the first was
between non-regular and regular use († ); the second was between
dependent and nondependent use (‡); and the third simultaneously
estimates the magnitude of association with non-dependent regular
use and dependent regular use (*). Results from the first model indi-
cate whether regular use in general is associated with the row variable
and from the second model indicate whether the association of the
row variable with dependent regular use is significantly stronger than
that with nondependent regular use. All models were adjusted for
gender and birth-cohort and the associations with affective and anxi-
ety disorders were additionally adjusted for substance disorders.
All data management and analyses were conducted using SAS
software (SAS, 1996) and relative weights (the sum of the weights
equals the number of respondents) [19].
Results
Use, Regular Use and Dependence: Incidence and
Prevalence
As shown in table 1, the cumulative incidence (CI) of
ever using tobacco is greater for men than women and
increases with age reaching 85% of men and 78% of wom-
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Table 1. Tobacco1 use and regular use
(%) in the total population Age
(years)
Ever use2
men women
Lifetime regular use3
men women
12-month regular use3
men women
14–24 79.9 * 72.8 36.5 35.2 32.8 31.3
14–15 64.5 61.4 12.7 17.8 12.5 17.4
16–17 79.1 * 70.1 31.9 30.0 31.0 27.7
18–21 80.3 * 72.5 43.3 * 34.6 40.6 * 32.6
22–24 85.3 * 77.5 43.1 43.1 36.5 36.0
Men: n = 1,493; women: n = 1,528.
* ¯21, p ! 0.05.
1 Tobacco products were described as: cigarettes, cigars, pipes, snuff or chew.
2 Use = Ever used a nicotine product at least once.
3 Regular use = Ever used a nicotine product daily for 4 weeks or more.
Table 2. Lifetime cumulative incidence (%) and 12-month prevalence (%) of DSM-IV nicotine dependence in the
total population and among regular users
Age
(years)
Lifetime cumulative incidence
total population1
men women
lifetime regular users2
men women
12-month prevalence
total population
men women
12-month
regular users3
men women
14–24 19.1 18.5 52.2 52.6 15.8 14.1 47.0 44.1
14–15 6.5 8.9 50.9 50.1 6.0 8.7 48.0 49.9
16–17 16.2 18.9 50.7 63.1 14.8 16.8 47.6 58.7
18–21 22.1 17.5 51.2 50.7 18.5 14.0 45.6 42.9
22–24 23.0 22.1 53.3 51.4 18.1 15.1 47.5 40.2
1 Total population – men: n = 1,493; women: n = 1,528.
2 Lifetime regular users = Ever used a nicotine product daily for 4 weeks or more: men: n = 545; women: n = 538.
3 12-Month regular users = Used a nicotine product daily for 4 weeks or more in the past 12 months: men: n = 489;
women: n = 478.
en by 22–24 years. Overall, the lifetime CI of regular use is
about half that of ever using, but this masks important
gender and age effects which show that women are more
likely to make the transition from ever use to regular use
and that the proportion of ever users making this transi-
tion increases sharply in the mid to late teens. The rela-
tively high prevalence of 12-month regular use reflects
this teen trend of recent incidence by remaining at 95% of
lifetime regular use through 21 years of age and then fall-
ing to 85% in the oldest age group reflecting an increasing
rate of remission.
Table 2 shows the lifetime CI and 12-month preva-
lence of nicotine dependence in the total population and
among regular users. Overall, about 19% of the popula-
tion meets criteria for lifetime and 15% for 12-month
nicotine dependence. For lifetime CI there were no signif-
icant gender differences, although a strong age effect (p !
0.05) resulted in a CI of 22–23% by 22–24 years of age.
However, this age effect can be attributed to that of the
transition to regular use (table 1) since the distribution of
dependence among regular users is generally consistent
across age groups at slightly more than 50%.
Criteria Prevalence by Level of Use
Table 3 shows the distribution of DSM-IV nicotine
dependence criteria among regular users and stratified by
the number of cigarettes smoked per day at peak use. (For
comparison purposes, cut points for the number of ciga-
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Table 3. Distribution (%) of DSM-IV
nicotine dependence criteria, diagnosis and
other indicators among regular users by
number of cigarettes smoked at the time of
peak use
DSM-IV criteria, diagnosis
and other indicators
Total n cigarettes/day at peak use1
1–14 15–24 25+
Number
Just one criterion 16.0 25.5 16.8 2.6
Just two criteria 23.7 28.8 26.0 14.2
Three or more criteria 53.5 * 34.3 49.9 83.2
Clustering of 3+ criteria2 98.0 96.6 96.8 99.6
Type
1 tolerance 23.8 20.4 25.3 25.2
2 withdrawal 36.9 * 23.2 39.8 50.3
3 more/longer than intended 47.8 * 43.0 45.6 57.7
4 unsuccessful cut-down 81.9 79.5 83.0 83.2
5 a lot of time using 27.5 * 0.0 2.1 100.0
6 activities given up 7.1 6.1 6.3 9.9
7 continued use despite problems 49.6 * 32.0 50.9 70.8
DSM-IV nicotine dependence 52.4 * 33.2 48.3 82.9
Craving 36.0 * 21.1 35.9 54.8
Reported dependence 55.0 * 36.6 59.0 72.9
* ¯2, p ! 0.05 test of differences in prevalence between levels of use.
1 Among regular users (n = 1,084): 34% reported 1–14/day; 39% reported 15–24/day; 27%
reported 25+/day.
2 12-month clustering among those with 3 or more criteria.
rettes smoked daily at peak use were based on those used
by the US National Centers for Disease Control in their
report Surveillance for Tobacco-Use Behaviors [27].)
As can be seen, the number of regular users reporting
any criteria and the number of reported criteria increases
significantly as peak use increases with the reported clus-
tering of 3 or more criteria remaining high at all levels of
use. Dose-response relationships were significant for four
of seven criteria: (2) withdrawal; (3) using more or longer
than intended (chain smoking); (5) a lot of time spent
using, and (7) continued use despite problems, repre-
senting symptoms of physiologic adaptation and loss of
control. Among those not showing a response to changes
in levels of use, (4) unsuccessful cut-down was uniformly
high across all levels (82%) possibly indicating a low
response-threshold, with (1) tolerance being moderately
low (24%) possibly indicating a high response-threshold,
and (6) giving up activities being relatively uncommon
(7%) most likely reflecting the social acceptance of tobac-
co use.
The proportion of regular users fulfilling criteria for
dependence also increased relative to peak use from 33%
among those using the least up to 48% and then to 83%
among those using the most. Among regular users, 78% of
dependence diagnoses included the physiologic symp-
toms of tolerance or withdrawal. Craving was reported by
36% of users overall and also exhibited a significant dose-
response relationship. After controlling for level of peak
use, these distributions were not significantly different
between older and younger regular users.
Course
Figure 1 shows the cumulative incidence of nicotine
use, regular use and dependence as estimated by survival
analyses and shows the significant birth-cohort effects
which are apparent for each of these outcomes (no gender
differences were found). Investigation of these effects
shows that the cohort differences in ever use but not regu-
lar use persist even after removing outcomes with onsets
in early childhood.
As seen in the data from the most recent birth-cohort,
beginning at around 10 years of age the incidence of first
use begins to rise with peak incidence seen at 12–15 years.
This is followed by peak incidence of regular use at 13–18
years of age and of nicotine dependence beginning at 15
years of age. It is interesting to note that peak incidence of
first use ends in the mid-teens followed by regular use in
the late teens, while the cumulative incidence of depen-
U59:ZEUAR131XA SIBY
46 Eur Addict Res 1998;4:42–49 Nelson/Wittchen
Fig. 1. Cumulative incidence of tobacco use, regular use and dependence.
dence appears to continue into adulthood. Gender differ-
ences were significant only for ever use with men being
significantly more likely than women to ever use a tobac-
co product with cohort effects being similar for both men
and women.
Table 4 shows state stability by comparing the use/
diagnosis status at 13+ months in the past to that of the
past 12 months. The table is stratified by gender, with
men in the upper panel (I) and women in the lower panel
(II). The table is organized with past status on the left mar-
gin (r1–r4) and current status across the top margin (c1–
c4) with the hierarchical status defined as: (1) never used/
quit; (2) ever use; (3) regular use, and (4) dependence. In
addition, the diagonal of the matrix is shown in column 5
for clarity.
Focusing on past nondependent (r3) and dependent
(r4) regular users, the persistence of regular use in this
young population is reflected in the findings that approxi-
mately three-quarters of respondents remained in the
same nondependence/dependence state when their 12-
month status was assessed and an even higher proportion
remained regular users (89%), with most transitions
among regular users being between states of nondepen-
dence and dependence. Among transitions out of regular
use, nondependent regular users (r3) were more likely to
quit or use less-than-regularly than dependent regular
users (r4; 15% vs. 6%, p ! 0.05).
Table 5 shows differences in attitudes and attempted
cut-backs between lifetime nondependent and dependent
past-year regular users. As can be seen, dependent regular
users are significantly more likely to express an interest in
changing their pattern of use and are correspondingly
more likely to view their level of use as having a negative
health impact. Associated with these attitudes are signifi-
cantly more dependent users attempting to cut-back and
more persistence in these attempts as shown by the num-
ber of cut-backs attempted and use of special therapies.
Characteristics of Nondependent and Dependent
Regular Users
In table 6 we look at associations between regular
smoking and other substance and nonsubstance disorders.
Significant associations between regular smoking and a
row disorder are represented by (†) and significant differ-
ences in the magnitude of association between nondepen-
dent and dependent smoking are represented by (‡), with
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Table 4. Diagnosis stability: comparison
of past and current nicotine use/diagnosis
profiles and estimated 12-month incidence
and remission
Status at 13+ months
population and
smoking status1
cumulative
incidence
%
12-month status (row %)
never/
quit
(c1)
ever
used
(c2)
regular
use
(c3)
depen-
dence
(c4)
Stability
in a row
(%)
(c5)
I. Men
r1 Never 24.8 – 15.6 1.5 1.6 81.2
r2 Ever use2 41.6 –3 – 2.7 2.4 94.9
r3 Regular use 17.7 9.0 5.6 – 9.7 75.7
r4 Dependent use 16.0 2.6 2.7 15.5 – 79.1
II. Women
r1 Never 31.3 – 10.9 1.2 0.9 87.0
r2 Ever use2 36.2 –3 – 3.8 2.0 94.2
r3 Regular use 16.7 10.9 4.3 – 9.0 75.9
r4 Dependent use 15.8 5.2 1.9 19.7 – 73.3
1 Populations are defined by their past (13+ months) use/diagnosis status.
2 Snuff and chew users are considered to have initiated 112 months ago, with no assess-
ment of recency.
3 Nonuse in the past 12 months was assessed only among subgroups with past ‘regular use’
or ‘dependence’.
Table 5. Attitudes and attempted cut-backs among past-year reg-
ular smokers
Lt dependence
diagnosis (n = 966)
no
(45.3%)
yes
(54.7%)
Health effects, %
– – 10.2 * 15.7
– 17.0 26.3
c/– 65.9 53.2
c 7.0 4.8
Would like to change pattern of use, % 56.0 * 74.0
Ever attempted a cut-back, % 67.2 * 92.0
Number of attempts, median (max.) 2 (40) 3 (30)
Use of special therapy to aid cut-back, % 1.6 * 4.6
* ¯2, p ! 0.05.
all tests of associations controlling for age, gender and co-
occurring alcohol and illicit drug disorders.
As can be seen in the first section of columns in the
table, the prevalence of these outcomes increases consis-
tently from nonsmokers to nondependent smokers and
again for dependent smokers. These positive associations
are reflected in the prevalence odds ratios (POR) present-
ed in the second section of columns in the table which are
consistently greater than 1.0. By focusing on the associa-
tions with smoking we can also see that most of these are
significant (†) and are consistently stronger for dependent
smokers as compared to nondependent smokers (‡) with
most differences between smokers and nonsmokers being
accounted for by the dependent smokers, the exception
being for substance disorders.
Discussion
Consistent with the results of Breslau et al. [15] for
young adults in the United States, these results have
shown that slightly more than half of regular smokers will
meet criteria for nicotine dependence with the earliest
cases appearing in the mid-teens. Extending these find-
ings, our results show that, as compared to nondependent
smokers, dependent smokers were shown to be more per-
sistent smokers despite a higher recognition of the nega-
tive health effects associated with smoking, their greater
interest in changing their smoking practices and their
increased number of attempts at cutting-back. This is
perhaps not so surprising since over 90% of regular
smokers report at least one criterion of DSM-defined
substance dependence with symptoms of compulsive use
U59:ZEUAR131XA SIBY
48 Eur Addict Res 1998;4:42–49 Nelson/Wittchen
Table 6. Lifetime association of regular use and nicotine dependence with selected psychiatric disorders1
Co-occurring disorders Row diagnosis, %
no
use
smokers
no dx dx
Smokers2
nondependent
POR 95% CI
dependent
POR 95% CI
Substance disorders
Alcohol abuse 7.9
16.8 30.7 †‡ 1.80 (1.33–2.44)* 3.98 (3.04–5.22)*
Alcohol dependence 2.4 7.7 17.9 †‡ 2.52 (1.59–3.98)* 6.14 (4.14–9.11)*
Illicit abuse 0.5 8.1 11.9 † 13.78 (6.84–27.75)* 15.41 (7.76–30.62)*
Illicit dependence3 0.0 3.0 8.1 7.68 (4.13–14.29)*
Affective disorders, any 12.2 19.7 30.0 †‡ 1.58 (1.21–2.06)* 2.63 (2.06–3.35)*
Hypomania 1.1 2.0 2.7 † 1.86 (0.86–4.03) 2.21 (1.72–4.56)*
Mania, single episode 0.0 0.2 0.1 10.85 (0.35–339.6) 3.21 (0.05–195.6)
Bipolar I or II 1.3 1.2 4.1 ‡ 0.88 (0.36–2.14) 2.55 (1.36–4.78)*
Major depression 8.8 14.7 19.3 †‡ 1.57 (1.17–2.11)* 2.18 (1.65–2.89)*
Dysthymia 2.0 2.8 6.7 †‡ 1.28 (0.68–2.40) 2.86 (1.73–4.75)*
Anxiety disorders, any 11.5 13.4 23.0 †‡ 1.10 (0.81–1.48) 1.94 (1.49–2.53)*
Panic attack 2.4 4.0 11.3 †‡ 1.48 (0.86–2.54) 3.71 (2.41–5.70)*
Panic disorder 0.7 1.8 2.2 – 2.12 (0.83–5.45) 2.07 (0.78–5.45)
Agoraphobia 1.6 2.5 6.4 †‡ 1.50 (0.71–3.15) 3.06 (1.64–5.70)*
Social phobia 1.9 2.3 5.1 – 1.11 (0.53–2.31) 2.20 (1.19–4.07)*
Simple phobia, any 1.0 1.4 4.3 †‡ 1.34 (0.52–3.47) 3.74 (1.80–7.77)*
Blood/injection phobia 0.1 0.7 1.5 † 6.09 (0.94–39.62) 10.05 (1.72–58.76)*
Phobia NOS 4.4 2.4 6.9 ‡ 0.58 (0.30–1.14) 1.63 (1.00–2.66)*
Generalized anxiety 0.1 1.2 2.1 † 14.55 (1.76–120.2)* 14.53 (1.74–121.4)*
Obsessive-compulsive 0.3 1.2 0.9 – 3.90 (1.07–14.19)* 2.19 (0.49–9.83)
Posttraumatic stress 0.3 0.4 2.8 †‡ 1.06 (0.18–6.29) 5.78 (1.86–17.98)
† Indicates a significant difference (p ! 0.05) between nonregular use and regular use, regardless of dependence.
‡ Indicates a significant difference (p ! 0.05) between nondependent and dependent regular use.
* ¯2, p ! 0.05.
1 Dx = dependence; POR = prevalence odds ratio; CI = confidence interval. Lifetime cumulative incidence of no use (less than regular use) =
64.1%, of regular use = 17.1%, and of dependence = 18.8%. Reported ORs reflect the association with nondependent regular use (regular use)
and dependent regular use (dependence), modeled simultaneously.
2 Controls for alcohol and illicit substance disorders in addition to gender and birth-cohort.
3 All persons reporting illicit substance dependence were also regular users.
and physiologic adaptation being among the most often
reported.
Our analysis of the association between regular smoking
and other psychopathology showed that, consistent with
earlier findings from the ECA [12], regular smoking is
strongly associated with other substance, affective and anx-
iety disorders. However, we also showed that the cumula-
tive incidence of these disorders is significantly higher
among dependent smokers than nondependent smokers,
even for disorders with a relatively high prevalence among
nonsmokers such as major depression, dysthymia, pan-
ic attacks, agoraphobia, posttraumatic stress disorder
(PTSD) and the alcohol disorders. With few exceptions, it
appears that dependent regular smoking is responsible for
the previously reported association between regular smok-
ing and nonsubstance psychopathology.
These results should be interpreted with the knowledge
that they are based on retrospective reports collected
using fully structured diagnostic instruments adminis-
tered by lay interviewers. Despite the proven reliability
and validity of these instruments, it is unrealistic to
expect that such data will match the accuracy of informa-
tion collected in the context of a clinical evaluation over
time using multiple informants. In addition, some respon-
dents may underreport their level of symptomatology
leading to the underestimation of prevalence and strength
U59:ZEUAR131XA SIBY
DSM-IV Nicotine Dependence Eur Addict Res 1998;4:42–49 49
of association between diagnoses. However, the basic
findings from this report would not be changed if it were
the case that symptomatology is underreported. In fact, in
the absence of this information bias we would expect a
confirmation of these findings in the form of stronger
associations.
This report is among the few that have been published
to date examining differences between nondependent and
dependent smokers and of the co-occurrence dependence
with other substance and nonsubstance disorders. In ad-
dition, it is the only general population study we are aware
of which shows associations with specific substance, affec-
tive and anxiety disorders. The pattern of strong associa-
tion which was identified indicates a common liability for
these substance disorder outcomes may exist in the form
of a coping strategy or biologic susceptibility and deserves
further investigation. Although it remains to be seen, it
can be hypothesized that comorbid dependent smokers
are more persistent smokers and may not respond suc-
cessfully to intervention therapy without recognition of
the underlying psychopathology. Whether this is related
to more severe withdrawal symptoms [28] and/or the trig-
gering of depressive episodes [29, 30] has yet to be investi-
gated.
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